Inventor
KOFINK CHRISTIANE
AT12 patents
⚠️ This page may combine multiple inventors who share the name “KOFINK CHRISTIANE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM INT
9 patentsUS10898487B2Jan 26, 2021
Benzylamino substituted quinazolines and derivatives as SOS1 inhibitors
BOEHRINGER INGELHEIM INT8 citations83
US10144739B2Dec 4, 2018
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
BOEHRINGER INGELHEIM INT9 citations82
US10829487B2Nov 10, 2020
Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors
BOEHRINGER INGELHEIM INT5 citations72
US10138251B2Nov 27, 2018
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
BOEHRINGER INGELHEIM INT6 citations71
US12053473B2Aug 6, 2024
Benzylamino substituted quinazolines and derivatives as SOS1 inhibitors
BOEHRINGER INGELHEIM INT1 citations62
USRE50594ESep 23, 2025
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
BOEHRINGER INGELHEIM INT0 citations60
US10882866B1Jan 5, 2021
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
BOEHRINGER INGELHEIM INT0 citations60
US11814380B2Nov 14, 2023
Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors
BOEHRINGER INGELHEIM INT0 citations56
US10717742B2Jul 21, 2020
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
BOEHRINGER INGELHEIM INT0 citations49